3
Oct 19 (Reuters) – NextCell Pharma AB: * PROTRANS-YOUNG CLINICAL TRIAL HAVE NOT YET BEEN REPORTED TO COMPANY * EXTENDED TIMELINE IS DUE TO FINAL ADMINISTRATIVE PROCESSING AND SIGN-OFF OF STUDY DATA
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
